ArticleJAAD international2025

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Weiran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.